New drug trial shows promise in treating advanced pancreatic cancer
A new pill called daraxonrasib has stopped tumour growth in nearly all of the 61 patients involved in a recent trial, with some seeing their cancer become undetectable. While further studies are needed to determine long-term outcomes, the results offer a potential new way to extend life for those facing a diagnosis with historically low survival rates.
Source: Guardian Science
National
Read the full story